v3.22.2.2
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues $ 20,178 $ 20,545 $ 61,406 $ 68,670
Cost of goods sold 5,486 6,811 18,310 20,278
Gross profit 14,692 13,734 43,096 48,392
Operating Expenses:        
General and administrative 23,855 27,564 73,461 79,264
Research and development 3,872 2,901 12,402 8,960
Gain on acquisition contingency (6,691) (1,266) (17,184) (3,553)
Asset impairment and abandonments 2,335 5,411 4,270 9,794
Transaction and integration expenses 214 0 1,352 2,510
Total operating expenses 23,585 34,610 74,301 96,975
Other operating income, net (898) (3,932) (898) (3,932)
Operating loss (7,995) (16,944) (30,307) (44,651)
Other expense (income) - net        
Other expense (income) - net 330 (117) 379 (221)
Interest expense 252 0 756 0
Foreign exchange loss 1,268 471 2,677 921
Change in fair value of warrant liability (50) (7,739) (18,917) (10,262)
Total other expense (income) - net 1,800 (7,385) (15,105) (9,562)
(Loss) before income tax provision (9,795) (9,559) (15,202) (35,089)
Income tax provision (benefit) 38 (1,304) 292 (1,004)
Net loss from operations (9,833) (8,255) (15,494) (34,085)
Discontinued Operations (Note 3)        
Loss from operations of discontinued operations 0 0 0 (6,316)
Income tax (benefit) 0 (349) 0 (1,112)
Net income (loss) from discontinued operations 0 349 0 (5,204)
Net loss (9,833) (7,906) (15,494) (39,289)
Net income applicable to noncontrolling interests 0 0 0 0
Net income (9,833) (7,906) (15,494) (39,289)
Other comprehensive income (loss)        
Unrealized foreign currency translation loss (gain) 180 (362) (242) (398)
Total other comprehensive loss $ (10,013) $ (7,544) $ (15,252) $ (38,891)
Net loss from operations per share - basic (in dollars per share) $ (1.46) $ (1.79) $ (2.44) $ (8.73)
Net income (loss) from discontinued operations per common share - basic (in dollars per share) 0 0.08 0 (1.33)
Net loss per share applicable to Surgalign Holdings, Inc.- basic (in dollars per share) (1.46) (1.71) (2.44) (10.06)
Net loss from operations per share - diluted (in dollars per share) (1.46) (1.79) (2.44) (8.73)
Net income (loss) from discontinued operations per common share - diluted (in dollars per share) 0 0.08 0 (1.33)
Net loss per share applicable to Surgalign Holdings, Inc.- diluted (in dollars per share) $ (1.46) $ (1.71) $ (2.44) $ (10.06)
Weighted average basic shares (in shares) 6,739,234 4,610,596 6,356,655 3,904,509
Weighted average diluted shares (in shares) 6,739,234 4,610,596 6,356,655 3,904,509

Source